In support of this concept, 2A-DUB/MYSM1 was originally discovered as regulator of androgen receptor-dependent gene expression in a co-regulatory complex with histone acetylase p/CAF in prostate cancer cells that displayed reduced overall levels of H2A-K119ubi compared with normal prostate tissue [9]. This evidence concerns the gene MYSM1 and prostate carcinoma.